Back to EZorb Newsletter Index

EZorb
Issue 321
EZORB MONTHLY NEWSLETTER SEP 28, 2020

In this issue:

  1. Share Success: Letters From Readers
  2. Research News: Glucocorticoids May Cause Serious Infection in RA Patients
  3. Useful Links
  4. What Are Others Saying About EZorb and Marvlix?
1. Share Success: Letters From Readers

Letter I: From Joy
Received at Testimonial Submit Form Monday, March 30, 2020 at 10:23:00
(Unedited)

Hi Elixir Industry,

I wanted to tell you about the Ezorb.

When I started to take EZorb I was doing it because I had bone spurs in my lumbar region. Actually they were connected to the sacrum and at times they would hit the sciatic nerve.

I was 33 yrs old diagnosed with 24 of these beautiful little bone spurs the doctor told me I can do one or two things: I could either have epidural cortisone shots or I could go see this surgeon.

I said well what would the surgeon do he said he would go in and he would file all these bone spurs out of you but the only thing he would do other than that is fuse your back.

I looked at myself and I thought nah I'm 33 years old I don't want my back fused so I had some of the epidural cortisone shots which I will never in my life do again cortisone shots. I don't mind cocktail shots I don't mind epidurals not nice.

So I went on a search to find natural ways of getting rid of these bone spurs I found a few of them and they seem to help it the time and then after a while it was like you know.

I really need to find something so I was talking to my friend and she went online and she put bone spurs up in, this company came up Elixir Industry. She told me about it called me up at the same time she was looking at it and I went online and I'm like wow if this stuff really helps people I'll try it.

So long story short I tried it and it was amazing it really did help the bone spurs. I can now say I'm bone spur free. I am now 66 years old and one day I thought okay let's put it into your lotion so I did.

I didn't know what it was going to do. It snowed one day here in Utah this was back old probably 3 years ago. The snow was a 12" deep and 4in was ice. I was outside shoveling and normally my husband comes out and helps me but I never saw him all day long so that night when I came and he says well I would have helped you but my back has been hurting.

I looked at him and thought you're married to a massage therapist you don't tell her your back hurts, this is got to be a man thing. So I went downstairs to the massage room grab the lotion. It had the ezorb in it.

I put it on his back and he woke up the next morning and he didn't hurt. I told him that it was only 2 inches of snow out there the next day and ice is now I just want you to shovel the 2in not the now 15 in probably 6 in device.

I said that I'll take care of that and I glanced do the corner of my eye and I see him lifting the snow up over the fence was just a 4-foot fence so I walk up to him and said Jack you don't need to lift the snow over the fence I don't want you to hurt your back.

He looked at me and he said was there magic in that lotion. I'm like wow maybe it is, didn't really think anything about it so that night I had him put it on my back. Now he's not a massage therapist the regular person and so he put the lotion on my back.

I went to bed that night got up the next morning he was right there was magic in that lotion now.

My clients love it I love it. I have no arthritis in my hands my body loves it everybody's body loves it. My clients have all told me that you know with this COVID-19 virus going on, our body needs your lotion so I make sure that my clients get their little jar of lotion.

From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 120,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's life.

Please email your story to sharesuccess @ ezorbonline.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.

2. Research News: Glucocorticoids May Cause Serious Infection in RA Patients

Among patients with rheumatoid arthritis (RA) receiving stable DMARD treatment, long-term glucocorticoid use is associated with a dose-dependent increase in the risk for serious infection, with a “small but significant” risk even at the lowest doses, researchers report.

Therefore, “clinicians should avoid long-term use of higher-dose glucocorticoids and should weigh the benefits of low-dose therapy in individual patients with these potential risks,” Michael George (University of Pennsylvania, Philadelphia, USA) and colleagues write in the Annals of Internal Medicine.

The study drew on two US claims databases, Medicare (representing publicly insured patients aged 65 years and older) and Optum (representing commercially insured patients), to evaluate the risk for infection occurring during an acute care hospitalization over a total of 305,576 medication courses in 216,159 people with RA who were undergoing stable DMARD treatment. Approximately half of the medication courses included biologics or Janus kinase inhibitors.

In all, 47.1% of the 172,041 Medicare patients and 39.5% of the 44,118 Optum patients were taking glucocorticoids after 6 months of stable DMARD use, most commonly at a dose of 5 mg/day or lower.

George and team observed rising rates of hospitalized infection with increasing glucocorticoid doses in the Medicare cohort, at 8.4 per 100 person-years for those not taking the agents, and 13.5, 21.5, and 31.6 per 100 person-years for those taking low-dose (le 5 mg/day), medium-dose (gt 5-10 mg/day), and high-dose (gt 10 mg/day) glucocorticoids, respectively.

However, there was no further decrease in breast cancer mortality risk after this time in the early screening group versus controls, with 209 versus 474 deaths by the end of follow-up and a nonsignificant RR of 0.88.

In a model adjusting for potentially confounding factors, people taking any dose of glucocorticoids had a significantly higher risk for hospitalized infection than those not taking glucocorticoids, with a hazard ratio (HR) of 1.29 for those in the low-dose group, 1.72 for those in the medium-dose group, and 2.16 for those in the high-dose group.

The researchers describe a similar pattern of results for the Optum cohort, with corresponding HRs of 1.32, 2.07, and 2.76.

“To put the observed risk into perspective, the risk for hospitalized infection associated with 5 mg or less of glucocorticoids per day was similar to the risk associated with biologic therapies in prior studies,” write the study authors. They note that this “may be helpful when counseling patients who require higher doses of glucocorticoids but who are hesitant to start a biologic treatment because of infection concerns.”

And the team concludes: “Our results support guideline recommendations to minimize the long-term use of glucocorticoids and attempt tapering, but the risks of low-dose glucocorticoids may be acceptable in patients who are obtaining substantial benefit and who have increased disease activity when attempts are made to taper.”

Original research was published in Ann Intern Med 2020; doi:10.7326/M20-1594.

3. Useful Links

EZorb - Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

4. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.


Copyright 2020 Elixir Industry

Back to EZorb Newsletter Index